Patients with non-Hodgkin lymphoma receiving treosulfan and fludarabine as reduced-intensity conditioning

被引：0
|
作者：
Schmitt, M. [1 ]
Trenschel, R. [2 ]
Sayer, H. G. [3 ]
Schneider, C. [1 ]
Glass, A. [4 ]
Hilgendorf, I. [1 ]
Treschl, A. [3 ]
Junghanss, C. [1 ]
Borchert, K. [1 ]
Koenigsmann, M.
Casper, J. [5 ]
Beelen, D. W. [2 ]
Freund, M. [1 ]
Kahl, C. [6 ]
机构：
[1] Univ Rostock, Dept Internal Med 3, Rostock, Germany
[2] Univ Essen Gesamthsch, Dept Internal Med, Essen, Germany
[3] Univ Jena, Dept Internal Med, Jena, Germany
[4] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany
[5] Klinikum Oldenburg, Transplant Unit, Oldenburg, Germany
[6] Klinikum Magdeburg, Dept Hematol & Oncol, Magdeburg, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：299 / 300
页数：2
相关论文
共 50 条
  • [31] Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma
    Corradini, P
    Bregni, M
    Tarella, C
    Olivieri, A
    Dodero, A
    Farina, L
    Zallio, F
    Leoni, P
    Ciceri, F
    Devizzi, L
    Benedetti, F
    Pogliani, E
    Rambaldi, A
    Locasciulli, A
    Falda, M
    Santoro, A
    Scime, R
    Gianni, AM
    BONE MARROW TRANSPLANTATION, 2003, 31 : S57 - S57
  • [32] Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma
    Clavert, Aline
    Le Gouill, Steven
    Brissot, Eolia
    Dubruille, Viviane
    Mahe, Beatrice
    Gastinne, Thomas
    Blin, Nicolas
    Chevallier, Patrice
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Saulquin, Beatrice
    Moreau, Anne
    Moreau, Philippe
    Harousseau, Jean-Luc
    Milpied, Noel
    Mohty, Mohamad
    LEUKEMIA & LYMPHOMA, 2010, 51 (08) : 1502 - 1508
  • [33] Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
    Epperla, Narendranath
    Ahn, Kwang Woo
    Armand, Philippe
    Jaglowski, Samantha
    Ahmed, Sairah
    Kenkre, Vaishalee P.
    Savani, Bipin
    Jagasia, Madan
    Shah, Nirav N.
    Fenske, Timothy S.
    Sureda, Anna
    Smith, Sonali M.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) : 78 - 85
  • [34] Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma
    Rodriguez, Roberto
    Nademanee, Auayporn
    Ruel, Nora
    Smith, Eileen
    Krishnan, Amrita
    Popplewell, Leslie
    Zain, Jasmine
    Patane, Kathy
    Kogut, Neil
    Nakamura, Ryotaro
    Sarkodee-Adoo, Clarence
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (12) : 1326 - 1334
  • [35] Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma
    de lavallade, Hugues
    Cassier, Philippe A.
    Bouabdallah, Reda
    El-Cheikh, Jean
    Faucher, Catherine
    Fuerst, Sabine
    Coso, Diane
    Sainty, Danielle
    Arnoulet, Christine
    Gastaut, Jean-Albert
    Chetaille, Bruno
    Xerri, Luc
    Blaise, Didier
    Mohty, Mohamad
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (05) : 848 - 850
  • [36] Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma
    A Shimoni
    S T Zwas
    Y Oksman
    I Hardan
    N Shem-Tov
    A Rand
    R Yerushalmi
    A Avigdor
    I Ben-Bassat
    A Nagler
    Bone Marrow Transplantation, 2008, 41 : 355 - 361
  • [37] Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma
    Shimoni, A.
    Zwas, S. T.
    Oksman, Y.
    Hardan, I.
    Shem-Tov, N.
    Rand, A.
    Yerushalmi, R.
    Avigdor, A.
    Ben-Bassat, I.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 (04) : 355 - 361
  • [38] Clinical and molecular disease eradication in patients with poor prognosis non-Hodgkin lymphoma by allogeneic haematopoietic stem cell transplantation with reduced-intensity or myeloablative conditioning
    Mitterbauer, M
    Kalhs, P
    Jaeger, U
    Mannhalter, C
    Rabitsch, W
    Fischer, G
    Dieckmann, K
    Simonitsch-Klupp, I
    Hoecker, P
    Hinterberger, W
    Rosenmayr, A
    Mitterbauer, G
    Greinix, HT
    BONE MARROW TRANSPLANTATION, 2005, 35 : S73 - S73
  • [39] Is Treosulfan-Based Conditioning Attractive as a Reduced-Intensity Conditioning Regimen in Korea?
    Kim, Se Hyung
    Ji, Young Sok
    Yun, Jina
    Choi, Seong Hyeok
    Lim, Sung Hee
    Kim, Chan Kyu
    Park, Seong Kyu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (36)
  • [40] Feasibility of allogeneic hematopoietic stem cell transplantation (HSCT) with a reduced-intensity (RI) conditioning regimen for non-Hodgkin's lymphoma (NHL).
    Kusumi, E
    Tanimoto, TE
    Kami, M
    Hamaki, T
    Yuji, K
    Ueyama, J
    Miyakoshi, S
    Morinaga, S
    Kanda, Y
    Makimoto, A
    Kataoka, I
    Kim, SW
    Ohnishi, M
    Nakai, K
    Tobinai, K
    Tanosaki, R
    Mineishi, S
    Takaue, Y
    Mutou, Y
    BLOOD, 2001, 98 (11) : 377B - 377B
12345